Cardiovascular
The most heavily tested system. The vast majority of vignettes collapse into five chief complaints: chest pain, dyspnea, palpitations, syncope, and edema. Master these entry points and the pathophysiology follows.
Chief complaints
Vignettes enter through one of these doors. Each complaint lays out the full differential, marks the can't-miss diagnoses, and tells you the next right action for each.
Chest pain
The most common can't-miss complaint on the exam. Six killers to exclude before anything else.
The reflex: is this cardiac, vascular, pulmonary, GI, or musculoskeletal? ECG within 10 minutes and troponin in almost any adult with new chest pain. Tearing pain radiating to the back is dissection. Pleuritic with dyspnea is PE. Pleuritic with fever is pneumonia or pericarditis. Exertional substernal with radiation is ACS. Postprandial burning is GERD. Reproducible with palpation is costochondritis.
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| STEMI / NSTEMI | Exertional or at-rest pressure, radiates to arm/jaw, diaphoresis, dyspnea. Risk factors stacked. ECG changes. | ECG in 10 min · troponin · aspirin 325 mg chewed. STEMI → cath within 90 min |
| Aortic dissection | Tearing/ripping pain radiating to back, unequal BP between arms, widened mediastinum on CXR, Marfan or uncontrolled HTN. | CT angio chest (stable) or TEE (unstable) · esmolol first, then nitroprusside |
| Pulmonary embolism | Pleuritic, dyspnea, tachycardia, recent immobilization or surgery or malignancy, unilateral leg swelling. | Wells score → D-dimer if low, CT-PA if intermediate/high · anticoagulate |
| Tension pneumothorax | Sudden, unilateral absent breath sounds, tracheal deviation away, hypotension, distended neck veins. | Immediate needle decompression 2nd ICS midclavicular · chest tube after |
| Cardiac tamponade | Beck triad: hypotension, JVD, muffled heart sounds. Pulsus paradoxus > 10 mmHg. | Bedside echo · pericardiocentesis |
| Esophageal rupture (Boerhaave) | Severe retrosternal pain after forceful vomiting, subcutaneous crepitus, pleural effusion. | Gastrografin esophagram · broad-spectrum antibiotics · surgical consult |
| Stable angina | Predictable exertional pain, relieved by rest or nitro, < 10 minutes. | Stress test, exercise ECG if baseline interpretable and can exercise |
| Pericarditis | Pleuritic, positional (worse supine, better leaning forward), friction rub, diffuse ST elevation with PR depression. | ECG · echo · NSAIDs + colchicine |
| GERD | Burning, postprandial, worse supine, responds to antacids. | Empiric PPI trial · endoscopy if alarm features |
| Costochondritis | Reproducible with palpation of costal cartilage, young patient, normal vitals. | NSAIDs · diagnosis of exclusion |
Dyspnea (cardiac)
Is this left heart, right heart, pulmonary, or something else entirely?
Dyspnea is cardiac when orthopnea, PND, elevated JVP, or S3 is present. BNP differentiates cardiac from pulmonary in ambiguous presentations, BNP < 100 makes HF unlikely. CXR shows pulmonary edema. Echo is the next step to characterize EF and valve function.
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| Acute decompensated HFrEF | Orthopnea, PND, S3, bilateral crackles, edema, elevated JVP, pink frothy sputum if flash. | IV loop diuretic · nitrates · O2 · upright position · BiPAP if distress |
| Acute valvular failure | Sudden dyspnea after MI (papillary rupture → MR) or endocarditis (AR). New loud murmur. | Bedside echo · emergent surgical consult |
| Cardiogenic shock | Hypotension, cold extremities, altered mental status, oliguria after large MI or fulminant myocarditis. | Pressors (norepinephrine), inotropes (dobutamine), revascularization · IABP/Impella |
| Tamponade | Beck triad, pulsus paradoxus. | Echo · pericardiocentesis |
| HFpEF | Same symptoms as HFrEF but EF ≥ 50%. Older, HTN, diabetic, obese female phenotype. | Diuretics for symptoms · SGLT2 inhibitor · treat comorbidities |
| High-output failure | Warm extremities, bounding pulses. Anemia, thyrotoxicosis, AV fistula, Paget, beriberi. | Treat underlying cause |
Palpitations
Stability first. Then: is the rhythm narrow or wide, regular or irregular?
Unstable (hypotension, altered mental status, chest pain, pulmonary edema) gets synchronized cardioversion. Stable gets an ECG. Four buckets: narrow regular (SVT, sinus, atrial flutter), narrow irregular (AFib, MAT), wide regular (VT, SVT with aberrancy), wide irregular (polymorphic VT, AFib with WPW).
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| Ventricular tachycardia | Wide complex regular, structural heart disease or ischemia, AV dissociation, fusion beats, capture beats. | Unstable → cardioversion · stable → amiodarone or procainamide |
| Torsades de pointes | Polymorphic VT with long QT baseline. Drugs (fluoroquinolones, antipsychotics, methadone), hypokalemia, hypomagnesemia. | IV magnesium 2 g · stop offending drug · correct K · overdrive pacing if refractory |
| WPW with AFib | Irregular, wide complex, very rapid (> 200). Delta wave on baseline ECG. | Procainamide or ibutilide. AVOID AV nodal blockers, preferential conduction down accessory pathway → VF |
| Atrial fibrillation with RVR | Irregularly irregular, narrow complex, rate > 100. Palpitations, dyspnea. | Rate control (metoprolol, diltiazem) · anticoagulate by CHA2DS2-VASc |
| SVT (AVNRT) | Sudden onset narrow complex tachycardia, rate 150–220, young patient without structural disease. | Vagal maneuvers → adenosine 6 mg IV → 12 mg → cardioversion if unstable |
| Sinus tachycardia | Gradual onset, rate usually < 150, identifiable trigger (pain, fever, volume depletion, anxiety, PE, anemia, hyperthyroid). | Find and treat the cause |
Syncope
The fundamental split: cardiac (dangerous) versus reflex or orthostatic (usually benign).
Cardiac syncope is sudden, no prodrome, exertional, injuries on impact, known heart disease, family history of sudden death. Reflex (vasovagal) has a prodrome (nausea, warmth, tunnel vision), is triggered by emotion or standing, resolves fast. Orthostatic happens on standing, with volume depletion, autonomic dysfunction, or medications.
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| Ventricular arrhythmia | Sudden, exertional, known HF or cardiomyopathy, prior MI, family history of SCD. | Admit · telemetry · echo · cardiology · consider ICD |
| Aortic stenosis | Exertional syncope in elderly, systolic crescendo-decrescendo murmur radiating to carotids, narrow pulse pressure. | Echo · surgical or transcatheter AVR |
| Hypertrophic cardiomyopathy | Young athlete with exertional syncope, family history of SCD, murmur increases with Valsalva. | Echo · beta-blocker · activity restriction · ICD if high-risk |
| Massive PE | Dyspnea, pleuritic pain, tachycardia, hypoxia, leg swelling. | CT-PA · anticoagulate · thrombolysis if shock |
| Aortic dissection | Tearing back pain, pulse differential. | CT angio |
| Vasovagal syncope | Young or healthy patient, prodrome of nausea/warmth/lightheadedness, triggered by pain or emotion, rapid recovery. | Reassurance · hydration · counterpressure maneuvers · tilt-table if recurrent unclear |
| Orthostatic hypotension | Syncope on standing, drop > 20 systolic or 10 diastolic, medications, dehydration, autonomic neuropathy. | Orthostatic vitals · hydration · medication review · compression stockings · midodrine |
Peripheral edema
Unilateral vs bilateral is the first fork. Bilateral is systemic; unilateral is local.
Bilateral edema: right heart failure, cirrhosis, nephrotic syndrome, hypoalbuminemia, drugs (CCBs, NSAIDs, TZDs), venous insufficiency, lymphedema. Unilateral: DVT, cellulitis, lymphatic obstruction, Baker cyst rupture, compartment syndrome.
| Diagnosis | Key features / clues | Next step |
|---|---|---|
| Deep vein thrombosis | Unilateral leg swelling, calf pain, recent immobility or malignancy. | Wells score → D-dimer if low, duplex US if high · anticoagulate |
| Right heart failure | Elevated JVP, hepatomegaly, ascites, bilateral lower extremity edema. Often from pulmonary HTN or left heart failure. | Echo · BNP · treat underlying cause |
| Nephrotic syndrome | Edema (often periorbital), proteinuria > 3.5 g/day, hypoalbuminemia, hyperlipidemia. | UA · urine protein/creatinine · renal biopsy often needed |
| Cirrhosis | Ascites > lower extremity edema, spider angiomata, palmar erythema, caput medusae. | RUQ US · LFTs · albumin · coags · MELD |
| Cellulitis | Unilateral, warm, erythematous, tender. Fever. Often preceded by break in skin. | Clinical diagnosis · cephalexin or cefazolin · cover MRSA if abscess or risk factors |
Disease deep dives
Once you've identified the likely diagnosis from the chief complaint, these pages give you the presentation, workup, management, and exam pearls in depth.
Acute Coronary Syndrome
A spectrum from unstable angina to NSTEMI to STEMI. The question on the exam is almost never the diagnosis, it's the next step.
Substernal pressure radiating to left arm or jaw, diaphoresis, nausea, dyspnea. Elderly, diabetics, and women often atypical: fatigue, epigastric pain, isolated dyspnea.
- ECG within 10 minutes. Differentiates STEMI (cath lab) from NSTEMI/UA (risk-stratified). Look for ST elevation, Q waves, T-wave inversions.
- Troponin. High-sensitivity troponin at 0 and 1–3 hours. Elevated confirms MI. Trend matters.
- CXR. Rules out aortic dissection (widened mediastinum), pneumothorax, pulmonary edema.
- Echo. Assesses wall motion abnormalities, EF, complications (tamponade, VSD, papillary rupture).
- Immediate therapy (MONA-B). Morphine (rare, only for refractory pain), Oxygen (only if SaO2 < 90), Nitrates (avoid in RV infarct or severe AS), Aspirin 325 mg chewed, Beta-blocker (only if no HF/shock).
- Dual antiplatelet. Aspirin + P2Y12 inhibitor (ticagrelor or prasugrel preferred over clopidogrel in most cases).
- Anticoagulation. Unfractionated heparin or enoxaparin until revascularization.
- STEMI, primary PCI. Door-to-balloon < 90 minutes. If PCI unavailable within 120 minutes, fibrinolysis within 30 minutes.
- NSTEMI/UA, risk stratify. TIMI or GRACE score. High-risk → cath within 24 hours. Low-risk → stress test after medical therapy.
- Post-MI medications. Aspirin indefinitely + P2Y12 for 12 months, beta-blocker, high-intensity statin (atorvastatin 80 or rosuvastatin 40), ACEi if EF < 40% or anterior MI, MRA if EF < 40% with HF or DM.
Heart Failure
Classify by EF (HFrEF vs HFpEF) and acuity (chronic vs decompensated). Treatment diverges meaningfully between the two.
Dyspnea, orthopnea, PND, fatigue, exercise intolerance. Exam: JVD, S3, bibasilar crackles, peripheral edema, hepatojugular reflux.
- BNP / NT-proBNP. BNP < 100 makes HF unlikely. Elevated in HF but also in PE, AFib, renal failure, sepsis.
- ECG + CXR. LVH, prior MI, cephalization, Kerley B lines, cardiomegaly, pleural effusions.
- Echo. The defining test. Quantifies EF, chamber size, valve function, wall motion. Determines HFrEF vs HFpEF.
- Labs. CBC, BMP, TSH, iron studies, HbA1c. HF can be caused or worsened by anemia, thyroid disease, hemochromatosis, diabetes.
- Acute decompensation. IV loop diuretic at 2.5× the home dose, O2 to SpO2 ≥ 92%, upright positioning, BiPAP if in respiratory distress. Add IV nitroglycerin if hypertensive.
- HFrEF quadruple therapy. All four reduce mortality. (1) ARNI (sacubitril-valsartan) or ACEi/ARB, (2) beta-blocker (carvedilol, metoprolol succinate, or bisoprolol), (3) MRA (spironolactone or eplerenone), (4) SGLT2 inhibitor (dapagliflozin or empagliflozin).
- HFrEF devices. ICD if EF ≤ 35% on guideline-directed medical therapy for ≥ 3 months. CRT if QRS ≥ 150 ms with LBBB.
- HFpEF. Diuretic for symptoms. SGLT2 inhibitor (empagliflozin, dapagliflozin) is now recommended. Aggressively control HTN, treat AFib, treat obesity.
- Lifestyle. Sodium restriction (< 2 g/day), fluid restriction if hyponatremic, daily weights, medication adherence, cardiac rehabilitation.
Atrial Fibrillation
Three questions define management: stable or unstable, rate or rhythm control, anticoagulate or not.
Palpitations, dyspnea, fatigue, sometimes syncope or stroke. Many patients are asymptomatic. Exam: irregularly irregular pulse.
- ECG. Irregularly irregular rhythm, no discrete P waves, variable R-R intervals.
- Echo. LA size, LV function, valve disease. Rheumatic mitral stenosis defines valvular AFib with different anticoagulation rules.
- TSH, BMP, CBC. Rule out hyperthyroidism, electrolyte abnormalities, anemia as triggers.
- Unstable → cardioversion. Hypotension, chest pain, pulmonary edema, altered mental status → synchronized DC cardioversion.
- Rate control. First-line for most. Beta-blocker (metoprolol) or non-dihydropyridine CCB (diltiazem). Digoxin in HF or refractory cases. Target HR < 110 (lenient) or < 80 (strict if symptomatic).
- Rhythm control. Consider in young, symptomatic, or new-onset AFib. Antiarrhythmics (flecainide or propafenone if no structural heart disease; amiodarone, dofetilide, sotalol otherwise). Catheter ablation is increasingly first-line.
- Anticoagulation. CHA2DS2-VASc ≥ 2 (male) or ≥ 3 (female) → anticoagulate. DOACs (apixaban, rivaroxaban, dabigatran, edoxaban) preferred over warfarin. Warfarin required for mechanical valves and moderate-severe mitral stenosis.
- Cardioversion safety. If AFib > 48 hours or unknown duration → 3 weeks of anticoagulation before or TEE to exclude LA thrombus, then 4 weeks of anticoagulation after.
Hypertension
Stages, targets, and when to act urgently. The most common chronic diagnosis on the exam.
Usually asymptomatic. End-organ signs: retinopathy, LVH, proteinuria. Malignant hypertension: headache, visual changes, encephalopathy.
- Confirm diagnosis. Two separate measurements on two separate visits OR ambulatory/home BP monitoring. Avoid white-coat overdiagnosis.
- Initial workup. BMP, lipids, glucose or HbA1c, UA, ECG. Looking for end-organ damage and establishing baseline.
- Secondary HTN screening. If resistant (3 drugs including diuretic), young onset, or specific features. Renal US/Doppler for renovascular disease, aldo/renin ratio for primary aldosteronism, plasma metanephrines for pheochromocytoma, cortisol for Cushing, polysomnography for OSA.
- Stage 1 (130–139/80–89). Lifestyle first. Drug therapy if ASCVD, DM, CKD, or 10-year ASCVD risk ≥ 10%.
- Stage 2 (≥ 140/90). Two-drug therapy: thiazide + ACEi/ARB or thiazide + CCB. Target < 130/80.
- First-line agents. Thiazide (chlorthalidone > HCTZ), ACEi/ARB, CCB (amlodipine). Beta-blockers are not first-line unless there's a CAD, HF, or arrhythmia indication.
- Black patients. Thiazide or CCB first, not ACEi/ARB (less effective as monotherapy).
- Special populations. DM or CKD → ACEi/ARB preferred. Pregnancy → labetalol, nifedipine, or methyldopa (avoid ACEi/ARB).
- Hypertensive emergency. BP > 180/120 WITH end-organ damage (encephalopathy, AKI, MI, dissection, pulmonary edema). IV therapy (labetalol, nicardipine, nitroprusside, esmolol for dissection). Reduce by no more than 25% in the first hour.
- Hypertensive urgency. Same BP, no end-organ damage. Oral therapy with gradual reduction over 24–48 hours.
Aortic Dissection
Tearing pain radiating to the back with unequal arm pressures. Stanford A (ascending) is surgical; B (descending) is medical.
Sudden, severe, tearing or ripping pain radiating to the back or interscapular area. Risk factors: uncontrolled HTN, Marfan syndrome, bicuspid aortic valve, pregnancy, cocaine use. Exam: pulse differential > 20 mmHg between arms, new AR murmur (if ascending), neurologic deficits (if carotid or spinal involvement).
- CT angio chest/abdomen. Test of choice in stable patients.
- TEE. If unstable or contrast contraindicated.
- CXR. Widened mediastinum in 75%, not sensitive enough to rule out.
- D-dimer. Useful to rule out if low pretest probability. Elevated in nearly all dissections.
- BP and HR control first. IV beta-blocker (esmolol or labetalol) FIRST to reduce shear stress. Target HR < 60, systolic BP 100–120.
- Add vasodilator. After beta-blockade, add nitroprusside or nicardipine if BP still elevated. Never give vasodilator first, reflex tachycardia increases shear stress.
- Pain control. IV opioids.
- Stanford A (ascending). Surgical emergency. Mortality 1–2% per hour untreated.
- Stanford B (descending only). Medical management unless complications (rupture, malperfusion, refractory pain, progression).